Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
glycoprotein\; involved in neuronal cell-to-cell interaction [RGD, Feb 2006].. Additionally we are shipping CD200 Kits (35) and CD200 Proteins (30) and many more products for this protein.
Showing 10 out of 306 products:
Rat (Rattus) Monoclonal CD200 Primary Antibody for FACS - ABIN120528
Barclay, Ward: Purification and chemical characterisation of membrane glycoproteins from rat thymocytes and brain, recognised by monoclonal antibody MRC OX 2. in European journal of biochemistry / FEBS 1983
Show all 7 references for ABIN120528
Rat (Rattus) Monoclonal CD200 Primary Antibody for FACS - ABIN120526
Barclay: The localization of populations of lymphocytes defined by monoclonal antibodies in rat lymphoid tissues. in Immunology 1981
Show all 4 references for ABIN120526
Human Polyclonal CD200 Primary Antibody for FACS, IHC - ABIN4900186
Petermann, Rozenberg, Zedek, Groben, McKinnon, Buehler, Kim, Shields, Penland, Bear, Thomas, Serody, Sharpless: CD200 is induced by ERK and is a potential therapeutic target in melanoma. in The Journal of clinical investigation 2007
Show all 4 references for ABIN4900186
Mouse (Murine) Monoclonal CD200 Primary Antibody for FACS - ABIN319959
Hoek, Ruuls, Murphy, Wright, Goddard, Zurawski, Blom, Homola, Streit, Brown, Barclay, Sedgwick: Down-regulation of the macrophage lineage through interaction with OX2 (CD200). in Science (New York, N.Y.) 2000
Show all 2 references for ABIN319959
Human Monoclonal CD200 Primary Antibody for FACS - ABIN4897318
Ramsay, Clear, Fatah, Gribben et al.: Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion ... in Blood 2012
Show all 2 references for ABIN4897318
Human Polyclonal CD200 Primary Antibody for ELISA, WB - ABIN1997709
Minas, Liversidge: Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal? in Critical reviews in immunology 2006
Mouse (Murine) Polyclonal CD200 Primary Antibody for FACS - ABIN4897320
Rate, Bosco, McKenna, Holt, Upham: Airway epithelial cells condition dendritic cells to express multiple immune surveillance genes. in PLoS ONE 2012
Rat (Rattus) Monoclonal CD200 Primary Antibody for ICC, FACS - ABIN256217
Crook, Hunt: Enrichment of early fetal-liver hemopoietic stem cells of the rat using monoclonal antibodies against the transferrin receptor, Thy-1, and MRC-OX82. in Developmental immunology 1996
Rat (Rattus) Monoclonal CD200 Primary Antibody for FACS, IHC (fro) - ABIN182015
McMaster, Williams: Identification of Ia glycoproteins in rat thymus and purification from rat spleen. in European journal of immunology 1980
Human Polyclonal CD200 Primary Antibody for IF (p), IHC (p) - ABIN761396
Clark, Arredondo, Dhesy-Thind: The CD200 tolerance-signaling molecule and its receptor, CD200R1, are expressed in human placental villus trophoblast and in peri-implant decidua by 5 weeks' gestation. in Journal of reproductive immunology 2015
The CD200:CD200R (show CD200R1 Antibodies) axis plays an immunoregulatory role in control of DSS (show PMP22 Antibodies) induced colitis in mice
Data show that neutrophil infiltration of tissues was markedly decreased in CD200 antigen (tg) transgenic animals and increased in CD200 receptor 1 CD200R1 (show CD200R1 Antibodies)(-/-) knockout mice.
we show a causal role for the CD200-CD200R (show CD200R1 Antibodies) inhibitory axis in arteriogenesis in a murine hindlimb ischemia model.
CD200 upregulation in reactive glial cells is modulated through PPAR-gamma (show PPARG Antibodies).
Anti-CD200R2 (show CD200R1L Antibodies), anti-IL-9 (show IL9 Antibodies), anti-IL-35, or anti-TGF-beta (show TGFB1 Antibodies) abolishes increased graft survival and Treg induction induced in cromolyn-treated CD200R1KO.CD200tg mice, and suggest combined role of mast cells and Tregs.
a role for both graft and host CD200/CD200R (show CD200R1 Antibodies) expression in increased allograft survival.
The main sites of CD200/CD200 receptor (CD200R (show CD200R1 Antibodies)) interaction in neonates and blood vessels, until adulthood, highlight the possible role of the CD200/CD200R (show CD200R1 Antibodies) system in microglial development and renewal.
CD200 may be expressed in the alternative activation of microglia and play a beneficial role in neuroinflammation.
a local (to the grafted tissue) tolerance mechanism initiated after CD200/CD200R (show CD200R1 Antibodies) engagement in primary graft recipients can lead to prolonged survival of grafts on transfer to secondary control nontransgenic recipients.
the increased CD200 expression by breast cancer cells (and/or host tissue) may be an important variable involved in determining the risk of metastasis.
this study shows that that CD200 suppresses the immune system's response to vaccines, and that blocking CD200 could improve the efficacy of cancer immunotherapy
These results suggest that CD200S activates TAMs to become DC-like antigen presenting cells, leading to the activation of CD8 (show CD8A Antibodies)(+) cytotoxic T lymphocytes, which induce apoptotic elimination of tumor cells.
increased expression of CD200, expansion of suppressive Treg cells and elevation of cytokines might have a role in multiple myeloma progression
In the present study, we showed for the first time a correlation between CD200 expression and the Wnt (show WNT2 Antibodies) signaling pathway in colon cancer cells.
data confirms that a functionally active CD200 extracellular moiety can be cleaved from the surface of CD200 expressing cells following ectodomain shedding
CD200 is a poor prognostic factor for overall survival in multiple myeloma (MM) patients. Bone marrow CD3 (show CD3 Antibodies) lymphocytes from MM patients express CD200 protein in higher proportion than healthy donors.
CD200 expression by cultured cultured bone marrow mesenchymal stem cells can be induced by both osteogenic and pro-inflammatory cytokines through the sole NF-kappaB (show NFKB1 Antibodies) pathway.
suggest that microglial activation may be partially caused by CD47 (show CD47 Antibodies)/signal regulatory protein-alpha (show SIRPA Antibodies)- and CD200/CD200R (show CD200R1 Antibodies)-mediated reductions in the immune inhibitory pathways
CD200 is up-regulated and may be a novel biomarker for the prognosis in cutaneous squamous cell carcinoma.
CD200 expression is a useful marker for evaluation of the severity of PCM (show PCMT1 Antibodies) and that lack of CD200 expression may improve the sensitivity of PCM (show PCMT1 Antibodies) to therapy with new drugs.
glycoprotein\; involved in neuronal cell-to-cell interaction
, CD200 antigen
, OX-2 membrane glycoprotein
, MRC OX-2 antigen
, antigen identified by monoclonal antibody MRC OX-2
, Cd200 antigen
, cell surface protein (thymocyte antigen identified by monoclonal antibody MRC-OX2)